PUBLISHER: Grand View Research | PRODUCT CODE: 1363257
PUBLISHER: Grand View Research | PRODUCT CODE: 1363257
The global cruciate ligament repair procedures market size is anticipated to reach USD 21.7 billion by 2030, according to a new report by Grand View Research, Inc.., growing at a notable CAGR of 7.2% from 2023 to 2030. The increasing incidence of ACL injuries drives the demand for cruciate ligament correction surgeries. Aperion Biologics' reveals that approximately 2.6 million anterior cruciate ligament (ACL) injuries are reported annually, with around 800,000 ACL repair surgeries performed globally. Moreover, the growing participation of younger individuals in sports activities and the continued involvement of players with a history of ACL injuries are among the factors expected to fuel the demand for ACL reconstruction procedures.
According to the World Health Organization (WHO), the COVID-19 pandemic had a negative impact on sports medicine and sports surgery. However, experts in arthroplasty and sports medicine used discontinuing unnecessary procedures during the pandemic as an opportunity to develop innovative methods for patient care and treatment options, as the Orthopedic Journal of Sports Medicine reported in November 2021. Despite these advancements, there is a concern that the increase in the waiting list for cruciate ligament repair procedures could widen the access gap and affect the market's growth rate in the coming years.
Furthermore, advances in technology have a significant impact on the field of cruciate ligament repair. This includes the development of minimally invasive surgical techniques, advanced imaging modalities for accurate diagnosis and preoperative planning, and innovative implant materials and devices. Technological developments improve the success rates of surgeries, shorten recovery times, and enhance patient satisfaction, driving the demand for cruciate ligament repair procedures. For instance, in March 2023, Arthrex, a US-based medical device company, designed the ACL TightRope surgical implant system to address orthopedic injuries, particularly ACL, in pediatric and young adolescent patients. Similarly, in September 2020, Ethicon, a Johnson & Johnson Medical Devices Companies division, introduced a new and user-friendly staple line reinforcement. This innovative device is designed for thoracic, bariatric, and general surgery procedures.